Skip to main content

Table 4 Cox proportional hazards regression analysis for patients with oral cavity squamous cell carcinoma

From: Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas

 

Oral Cavity HPV-associated

Oral Cavity HPV -

HR (95% CI)

P

HR (95% CI)

P

Mean age

1.02 (1.00–1.04)

0.010

1.02 (1.02–1.02)

< 0.001

Ethnicity

 White

1.00

 

1.00

 

 Black

1.88 (1.14–3.11)

0.013

0.93 (0.79–1.09)

0.41

 American Indian/Eskimo

a

 

1.18 (0.52–2.64)

0.68

 Asian/Pacific Islander

1.60 (0.64–4.00)

0.312

0.93 (0.71–1.22)

0.63

 Other

0.65 (0.09–4.78)

0.678

0.54 (0.30–0.99)

0.05

Sex

Men

1.00

 

1.00

 

Women

0.71 (0.50–0.99)

0.048

0.87 (0.78–0.95)

0.004

AJCC Clinical Staging

 T Staging

    

  T0

1.00

 

1.00

 

  T1

0.36 (0.07–1.65)

0.189

0.45 (0.14–1.43)

0.18

  T2

0.61 (0.13–2.80)

0.529

0.79 (0.25–2.49)

0.70

  T3

0.90 (0.19–4.21)

0.903

1.07 (0.34–3.38)

0.90

  T4

1.33 (0.29–5.98)

0.707

1.19 (0.37–3.73)

0.76

  TX

0.67 (0.11–4.00)

0.666

1.36 (0.39–4.70)

0.63

  N Staging

    

  N0

1.00

 

1.00

 

  N1

1.07 (0.70–1.63)

0.743

1.54 (1.34–1.77)

< 0.001

  N2

1.08 (0.75–1.55)

0.651

1.72 (1.52–1.94)

< 0.001

  N3

0.88 (0.26–2.93)

0.836

2.12 (1.49–3.03)

< 0.001

  NX

1.30 (0.17–9.88)

0.795

1.19 (0.75–1.89)

0.45

Insurance Status

 Not Insured

1.00

 

1.00

 

 Private Insurance/Managed Care

0.74 (0.42–1.32)

0.319

0.81 (0.65–1.00)

0.06

 Medicaid

1.82 (0.96–3.43)

0.064

1.27 (1.00–1.60)

0.043

 Medicare

1.32 (0.72–2.41)

0.355

1.04 (0.83–1.30)

0.72

 Other Government

0.83 (0.31–2.19)

0.713

1.17 (0.78–1.76)

0.44

Median Income Quartiles 2008–2012

  < $38,000

1.00

 

1.00

 

 $38,000–$47,999

1.38 (0.88–2.17)

0.160

0.84 (0.73–0.96)

0.02

 $48,000–$62,999

1.49 (0.96–2.33)

0.075

0.90 (0.79–1.03)

0.14

 $63,000 +

1.37 (0.87–2.16)

0.169

0.77 (0.67–0.88)

< 0.001

Treatment Group

 No treatment

1.00

 

1.00

 

 Radiation only

0.56 (0.25–1.23)

0.151

0.49 (0.37–0.63)

< 0.001

 Radiation and Chemo

0.42 (0.22–0.82)

0.011

0.44 (0.35–0.55)

< 0.001

 Surgery and Radiation

0.23 (0.10–0.50)

< 0.001

0.33 (0.26–0.43)

< 0.001

 Surgery, Chemotherapy and Radiation

0.59 (0.30–1.15)

0.127

0.42 (0.33–0.53)

< 0.001

 Surgery only

0.48 (0.24–0.94)

0.033

0.37 (0.29–0.45)

< 0.001

 Chemotherapy Only

1.18 (0.49–2.82)

0.710

0.84 (0.61–1.16)

0.31

  1. aInsufficient sample size